Navigation Links
CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
Date:5/3/2012

Basser, Senior Vice President of Clinical Research and Development at CSL Behring. "Subcutaneous administration of C1-esterase inhibitor will represent another important advance for patients suffering from the frequent and often debilitating attacks of HAE."

About Hereditary Angioedema

Hereditary angioedema (HAE), due to decreased C1-esterase inhibitor (C1-INH), is caused by mutations in SERPING1, the gene coding for C1-INH. It is inherited in an autosomal dominant manner. Symptoms of HAE include recurring episodes of edema, or swelling, in the hands, the feet, the face, the abdomen and/or the larynx. Patients who have abdominal attacks of HAE can experience episodes of severe pain, diarrhea, nausea and vomiting caused by swelling of the intestinal wall. HAE attacks that involve the face and larynx can result in airway closure, asphyxiation, and, if untreated, death. Diagnosis of HAE requires a blood test to confirm low or abnormal levels of C1-INH.  For more information about HAE, please visit www.haei.org.

CSL Behring has currently licensed treatments in Australia, Canada, Europe, Japan, the United States and several other countries in Asia and South America for treatment of acute attacks of HAE.

About CSL Behring

CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide. CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the wor
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period
2. CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
3. CSL Behring Recognized as a "Pioneer" By European Organisation for Rare Diseases (EURORDIS)
4. First Patient Screened in CSL Behring Global Phase I/III Study of Recombinant Single-Chain Factor VIII
5. CSL Behring Receives FDA Orphan Drug Designation for rVIIa-FP, a Novel Therapy in Development to Treat Hemophilia A and Hemophilia B Patients Who Have Inhibitors
6. CSL Behring Receives FDA Approval of Expanded Label on Berinert® for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
7. CSL Behring Seeks Proposals for Interlaken Leadership Awards, Supporting Innovative Research Into Neuroimmunology
8. CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment
9. National Organization for Rare Disorders Presents CSL Behring With 2011 Corporate Award
10. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
11. CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... RADNOR, Pa. , Nov. 26, 2014 ... dedicated to the development of innovative transdermal synthetic cannabinoid ... the Piper Jaffray 26th Annual Healthcare Conference 2014. The ... the New York Palace in New York ... , will present at 4:50 pm on Tuesday, December ...
(Date:11/26/2014)... -- According to the new research ... Battery, Pneumatic), by Product (Drill, Saw, Stapler, Reamer, ... (Orthopedic, ENT, Oral, Thoracic, Neurology) - Global Forecasts ... Instruments Market is estimated to be worth around ... expected to grow at a moderate CAGR during ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2
... 4, 2011 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... North America beyond physician offices and outpatient clinics with the ... and reference laboratories. The new line is expected to be ... regulatory approval and other requirements. Roche Diagnostics ...
... CLEMENTE, Calif., Oct. 4, 2011 ReShape Medical®, Inc. ... and chief executive officer.  Interim CEO, Ken Charhut, will ... chairman of the board for ReShape Medical.   ... and CEO of Luminous Medical, Inc., an innovative glucose ...
Cached Medicine Technology:Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2ReShape Medical Names Richard Thompson President and Chief Executive Officer 2
(Date:11/27/2014)... Ericdress.com today announced a site-wide ... to 85% off, on all its clothing, shoes and other ... 1 – 7, 2014 only. , At the special offer, ... above $109 can enjoy an extra $10 discount. Moreover, orders ... business specially recommended its new collection of 2015 evening dresses ...
(Date:11/27/2014)... As everyone knows, Cyber Monday is a crazy shopping ... Tidebuy is now providing many big promotions on its ... 15% of the current prices. The discount are up to ... free shipping (for orders above $88) from Dec. 1 – ... and more people are willing to shop on the internet. ...
(Date:11/27/2014)... 28, 2014 Recently, DressVe , the ... Cyber Monday Sales, which are valid during Nov. 29 – ... available on these new dresses, up to 90% off. In ... Click to view more at http://www.dressve.com/ , Dresses ... a great way to showcase somebody’s personality and figure. The ...
(Date:11/27/2014)... 2014 The report “Blepharitis – ... the therapeutic development for Blepharitis, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Blepharitis and special features on late-stage and ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 TORQ Cycle is ... professional instructors who go out of the way to help ... people to get fit and do their workouts sincerely using ... they understand the fact that it is important for people ... past year, they have made sure that people take to ...
Breaking Medicine News(10 mins):Health News:Ericdress.com Special Monday Sales Are Ready For Everyone 2Health News:Tidebuy.com Launching Overcoats Sales for the Special Monday in 2014 2Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 2Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 3Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 4Health News:The new wave in Fitness : Stay Active with Innovative Indoor Cycling Programs 2
... technology reduces radiation exposure, eliminates workflow complexity, and ... MEDRAD,s Intego(TM) PET Infusion System has been named ... innovative products of the year. The magazine ... readership considers to be the most far-reaching, game ...
... Members Say Patient Care at Risk With Threats ... from three major unions representing more than 3,000 ... Care (ARH) facilities in eastern Kentucky and southern ... of directors to meet with them to discuss ...
... Foundation Health Plan,Inc., Kaiser Foundation Hospitals and their subsidiaries ... quarter ended December 31,2008, compared to $9.6 billion in ... million in the fourth quarter of 2008, compared to ... year. The difference between the two,quarters was primarily ...
... general health, functioning improve , , FRIDAY, Feb. 13 ... lose weight, exercise can improve postmenopausal women,s quality of ... sedentary postmenopausal women (average age 57.4) randomly assigned to ... groups: an exercise expenditure of 4 kilocalories per kilogram ...
... As the FDA and pharmaceutical manufacturers contemplate ... plans for extended release opioids, thousands of clinicians ... discovered a resource that supports the safe and ... in Pain ( www.emergingsolutionsinpain.com ) is a ...
... more to promote awareness, study says , , FRIDAY, Feb. 13 ... name or role -- the doctors assigned to their care, ... "The majority of hospitalized patients we looked at were not ... study author Dr. Vineet Arora, associate program director at the ...
Cached Medicine News:Health News:MEDRAD Molecular Imaging Earns Top Rank in Innovation 2Health News:MEDRAD Molecular Imaging Earns Top Rank in Innovation 3Health News:Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals' Bottom Line 2Health News:Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals' Bottom Line 3Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 2Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 3Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 4Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 5Health News:Exercise Boosts Quality of Life in Postmenopausal Women 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 3Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: